Last Updated: June 11, 2026

ROPINIROLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ropinirole, and what generic alternatives are available?

Ropinirole is a drug marketed by Actavis Elizabeth, Alembic, Aurobindo Pharma Usa, Chartwell Rx, Dr Reddys Labs Ltd, Elite Labs Inc, Prinston Inc, Sandoz Inc, Watson Labs Inc, Accord Hlthcare, Alembic Ltd, Cosette, Epic Pharma Llc, Glenmark Pharms Ltd, Hikma, MLV, Orbion Pharms, Pharmobedient, and Zydus Lifesciences. and is included in twenty-one NDAs.

The generic ingredient in ROPINIROLE is ropinirole hydrochloride. There are fourteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ropinirole hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ropinirole

A generic version of ROPINIROLE was approved as ropinirole hydrochloride by PRINSTON INC on May 5th, 2008.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ROPINIROLE?
  • What are the global sales for ROPINIROLE?
  • What is Average Wholesale Price for ROPINIROLE?

US Patents and Regulatory Information for ROPINIROLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 077460-005 May 5, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mlv ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 079165-006 Feb 7, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz Inc ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 201047-006 Jun 6, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.